The relative potencies of cholinomimetics and muscarinic antagonists on the rat iris in vivo: effects of pH on potency of pirenzepine and telenzepine

Overview of attention for article published in Naunyn-Schmiedeberg's Archives of Pharmacology, November 1988

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)

Mentioned by

patent: 10 patents

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 13 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 10 patents that reference this research output.

Method for reducing intraocular pressure in the mammalian eye by administration of…

Grant US-5716952-A

United States of America

10 Feb 1998

Treatment and control of ocular development

Application US-5637604-A

United States of America

10 Jun 1997

Pharmacological treatment of ocular development

Application US-5571823-A

United States of America

05 Nov 1996

Gaba-ergic modulation of eye growth

Application US-5567731-A

United States of America

22 Oct 1996

Treatment and control of ocular development with a muscarinic antagonist

Application EP-0737475-A2

European Patent Office

16 Oct 1996

Treatment and control of ocular development with cholinergic agonists

Application EP-0629399-A1

European Patent Office

21 Dec 1994

OPHTHALMIC USE OF MUSCARINIC AGONISTS HAVING INCREASED DURATION OF ACTIVITY

Application WO-1994023719-A1

World Intellectual Property Organisation (WIPO)

27 Oct 1994

METHOD FOR REDUCING INTRAOCULAR PRESSURE IN THE MAMMALIAN EYE BY ADMINISTRATION OF…

Application WO-1993018772-A1

World Intellectual Property Organisation (WIPO)

30 Sep 1993

TREATMENT AND CONTROL OF OCULAR DEVELOPMENT

Application EP-0478694-A4

European Patent Office

29 Jul 1992

TREATMENT AND CONTROL OF OCULAR DEVELOPMENT.

Application EP-0478694-A1

European Patent Office

08 Apr 1992